Related Experiment Videos
Pseudohypoproteinemia and multiple myeloma
J H Avashia1, T D Walsh, R Valenzuela
1Department of Hematology, Cleveland Clinic Foundation, Ohio 44195.
Abstract:
Paraproteinemia is an important diagnostic feature of multiple myeloma. The M-protein level reflects tumor burden and helps to determine the response to chemotherapy. A case is described that illustrates the phenomenon of reversible in vitro gelification of an M-protein. Paraprotein IgG1-kappa formed a concentration- and temperature-dependent gel, which was reversed by agitation. Measurement of paraprotein without previous vortexing of the specimen can erroneously lower the apparent M-protein level as well as reduce serum viscosity levels. This phenomenon can downstage the disease at diagnosis, produce inappropriate assessment of treatment response, or lead to premature withdrawal of chemotherapy. In addition, misdiagnosis of hyperviscosity syndrome can occur with serious clinical consequences.
Insights
In multiple myeloma, M-protein gelification can falsely lower levels, impacting diagnosis and treatment. Proper sample handling, like vortexing, is crucial for accurate paraprotein measurement.
Area of Science:
- Clinical Chemistry
- Hematology
- Oncology
Background:
- Paraproteinemia, characterized by abnormal M-protein levels, is a key indicator in multiple myeloma diagnosis.
- M-protein levels are vital for assessing tumor burden and monitoring chemotherapy response.
Observation:
- A specific paraprotein (IgG1-kappa) exhibited reversible in vitro gelification.
- This gel formation was dependent on protein concentration and temperature, and reversed upon agitation.
Findings:
- Failure to vortex samples before measurement can lead to erroneously low M-protein levels and reduced serum viscosity.
- This artifact can result in understaging of multiple myeloma at diagnosis.
Implications:
- Inaccurate M-protein assessment can lead to inappropriate treatment response evaluation and premature chemotherapy cessation.
- Potential misdiagnosis of hyperviscosity syndrome carries significant clinical risks.